POM men’s are 2015 champs at softball titles

first_imgThe Melonas opened the scoring at the top of the second inning after Sammy Malum was walked to first base.Next batter up, Martin ToAlbert hit out to bring Malum home while he advanced to third base.Gerald Pokanau followed this up with a safe hit that brought ToAlbert home to make it 2-0.The Buluminski batters failed to get on base at their turn of bat as the game progressed to the third inning.The Melonas added another run in the third inning through a hit by pitch ball brought Eddie Simba to first base. Simba sprinted home after a power hit by Raymond Diou.Buliminski narrowed the deficit at the bottom of three when a hit by Bobby Bais scored two runners to trail 3-2.But with the flamboyant Tony Williams on the pitching mound for the Melonas, Buluminski failed to score any more runs.The bottom of the fifth saw Williams being taken off for Danny Tovia to take over the pitching duties.The Melonas gave themselves some breathing space scoring two more runs belted off the pitching of Anslom Bunbun in the sixth inningThe change in pitching paid dividends as the Melonas defended their lead to the last inning with Tovia striking out Collin Mangot in the final play to win the game.In the curtain raiser match, the Canberra Giants beat the Select Side 5-3.last_img read more

Cardiologist nominated to be next FDA chief

first_img Click to view the privacy policy. Required fields are indicated by an asterisk (*) President Barack Obama has nominated a veteran heart researcher who has run numerous large clinical trials to be the next head of the U.S. Food and Drug Administration (FDA). Robert Califf, currently FDA’s deputy commissioner for medical products and tobacco, was a top administrator and researcher at Duke University in Durham, North Carolina, for more than 30 years before coming to FDA earlier this year. If confirmed by the Senate, Califf would succeed Margaret Hamburg, who stepped down this past March.Califf, 63, “has long been considered a likely candidate for the top FDA job,” Brady Dennis reports in The Washington Post. “He has led scores of pivotal clinical trials, been among the nation’s most cited medical authors and for years served on various FDA advisory committees.”Reaction to the 15 September White House announcement has been positive. “Great news!,” tweeted Francis Collins, director of the National Institutes of Health. Email Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwecenter_img Sign up for our daily newsletter Get more great content like this delivered right to you! Country “He’s thoughtful and personable, and I’m sure will be a strong advocate on behalf of the FDA during a very critical period,” Aaron Kesselheim of Harvard Medical School told the Associated Press.Califf is “a soft-spoken Southerner with a passion for improving clinical trials,” and extensive knowledge of industry, Nature’s Heidi Ledford reported earlier this year.Califf’s confirmation is not assured. Numerous Obama administration nominees have never received confirmation votes, and many have bowed out of the process after waiting a year or more for Senate action.last_img read more